Economic Burden of AD

• Cost burden substantial in the US
• 2017 report from National Eczema Association estimates direct and indirect costs are $5.3 billion/year in the US
• Direct costs = prescriptions, consultations with clinicians, hospitalizations, transportation
• Indirect costs = missed work or school days, lost productivity, career setbacks, reduced QOL
• Survey of families with children with AD in 2015 reported expenditures of $274/month